You are here


New product launches, presence at trade fairs and congresses, scientific publications, strategic alliances, corporate developments... You’ll find all our news in this section. Don’t hesitate to get in touch with us if you require any further information.

Format: 08/12/2022
28 Sep 2021

The 28th Symposium on Glycosaminoglycans, an internationally renowned scientific event focusing on glycosaminoglycans, will be sponsored by Bioiberica, which will also be present at the event as a global life sci

4 Aug 2021
  • Bioiberica produces 20% of the world's Heparin API.
  • Heparin saves around a hundred million lives every year.
  • One out of every 5 doses of heparin administered in the world comes from Bioiberica.
2 Aug 2021
  • One of every 5 doses of heparine administered in the world comes from Bioiberica.
  • Several studies indicate that people hospitalized treated with anticoagulants, improved their chances of survival. 
1 Jul 2019
  • This online asset has a double aim: to offer information on the business unit, and to concentrate in a single place scientific, historical and general public information on heparin
  • Heparin is the most commonly used medicine for the prevention and treatment of thrombosis, and it is included in the list of essential medicines of the World Health Organization (WHO)
14 Mar 2019
  • Bioiberica’s Business Unit dedicated to the production of Heparin has the objective of establishing strategic alliances and finding new business opportunities in the US market
  • This is the largest professional and business meeting of the American pharmaceutical industry, which will include high level meetings, networking sessions and educational programs